Type of security: Stock
Sector: Capital Goods
The data is delayed by 15 minutes.
AXDX is in the long-term up 1159% in 16 years.
Description: Accelerate Diagnostics, Inc. focuses on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel system, a rapid diagnostic platform for rapid diagnosis in life-threatening infectious pathogens. It also develops and licenses OptiChem surface coatings for use in microarraying components. Accelerate Diagnostics, Inc. has a research collaboration with U.S. Centers for Disease Control and Prevention to develop tests for the rapid analysis of antibiotic-resistant biothreat agents based on Accelerate's high-speed identification and antibiotic susceptibility testing platform. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is based in Tucson, Arizona.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||-1.27||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||7.69%||Sales Growth - Q/Q||-82.28%||P/E||-21.97|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-54.67%||ROE||-58.87%||ROI|
|Current Ratio||17.04||Quick Ratio||Long Term Debt/Equity||Debt Ratio||0.06|
|Gross Margin||Operating Margin||-28957.4%||Net Profit Margin||-28383.6%||Dividend Payout Ratio|
|Cash From Financing Activities||30 K||Cash From Investing Activities||760 K||Cash From Operating Activities||-6.96 M||Gross Profit|
|Net Profit||-8.9 M||Operating Profit||-9.56 M||Total Assets||63.34 M||Total Current Assets||59.66 M|
|Total Current Liabilities||3.5 M||Total Debt||120 K||Total Liabilities||4.51 M||Total Revenue||10 K|
|High 52 week||24.65||Low 52 week||10.42||Last close||19.3||Last change||-1.48%|
|RSI||46.79||Average true range||0.97||Beta||0.46||Volume||123.45 K|
|Simple moving average 20 days||-0.24%||Simple moving average 50 days||-1.24%||Simple moving average 200 days||4.16%|
|Performance Week||-6.45%||Performance Month||5.18%||Performance Quart||-2.48%||Performance Half||34.03%|
|Performance Year||-12.27%||Performance Year-to-date||67.83%||Volatility daily||2.5%||Volatility weekly||5.58%|
|Volatility monthly||11.44%||Volatility yearly||39.61%||Relative Volume||281.89%||Average Volume||242.66 K|
|New High||New Low|
2020-05-26 08:51:12 | How Accelerate Diagnostics AXDX Stock Stands Out in a Strong Industry
2020-05-09 22:00:58 | Accelerate Diagnostics AXDX Q1 2020 Earnings Call Transcript
2020-05-08 01:12:36 | Edited Transcript of AXDX earnings conference call or presentation 7-May-20 8:30pm GMT
2020-04-28 08:00:15 | The Lakers Got Federal Aid and Your Corner Shop Didn’t
2020-04-22 12:00:04 | Accelerate Diagnostics AXDX Moves to Buy: Rationale Behind the Upgrade
2020-04-16 17:26:09 | Arizona diagnostics company collaborates on coronavirus antibody tests
2020-04-15 17:08:00 | Accelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; Schedules First Quarter 2020 Financial Results Conference Call for May 7, 2020
2020-04-15 17:07:00 | Accelerate Diagnostics and BioCheck Announce Commercial Supply and Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests
2020-04-01 15:30:24 | 3 Stocks Insiders Are Snapping Up
2020-03-05 16:18:07 | Edited Transcript of AXDX earnings conference call or presentation 27-Feb-20 9:30pm GMT
2020-02-20 12:31:05 | Earnings Preview: Accelerate Diagnostics AXDX Q4 Earnings Expected to Decline
2020-02-11 12:30:05 | Earnings Preview: Accelerate Diagnostics AXDX Q4 Earnings Expected to Decline
2019-12-22 16:42:48 | Is Accelerate Diagnostics Inc AXDX Going to Burn These Hedge Funds?
2019-12-08 15:00:00 | Accelerate Diagnostics CEO plans to retire in January; replacement named
2019-12-02 10:08:00 | Is Accelerate Diagnostics, Inc.'s NASDAQ:AXDX CEO Paid Enough Relative To Peers?
2019-12-02 08:00:00 | Accelerate Diagnostics Appoints Louise Francesconi to its Board of Directors
2019-11-25 21:08:41 | Edited Transcript of AXDX earnings conference call or presentation 7-Nov-19 9:30pm GMT
2019-11-18 10:04:09 | 12 Stocks With Short Ratios Above 50
2019-11-08 16:30:14 | Seven Arizona companies ranked among fastest growing by Deloitte
2019-11-07 18:25:11 | Accelerate Diagnostics AXDX Reports Q3 Loss, Misses Revenue Estimates
2019-11-07 16:01:00 | Accelerate Diagnostics Reports Third Quarter 2019 Financial Results
2019-11-04 07:45:00 | Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors
2019-10-28 18:15:22 | Is Accelerate Diagnostics Inc AXDX Going To Burn These Hedge Funds ?
2019-10-17 08:00:00 | Accelerate Diagnostics Schedules Call to Review Third Quarter 2019 Results
2019-09-19 08:00:18 | Just Two Stocks Turned Pennies Into Billions
2019-09-18 10:20:02 | Accelerate Diagnostics AXDX Jumps: Stock Rises 9.4%
2019-08-09 03:07:32 | Edited Transcript of AXDX earnings conference call or presentation 8-Aug-19 8:30pm GMT
2019-08-09 02:24:23 | Accelerate Diagnostics AXDX Q2 2019 Earnings Call Transcript
2019-08-08 18:05:10 | Accelerate Diagnostics AXDX Reports Q2 Loss, Misses Revenue Estimates
2019-08-08 16:06:00 | Accelerate Diagnostics Names Jack Phillips Chief Operating Officer
2019-08-08 16:01:00 | Accelerate Diagnostics Reports Second Quarter 2019 Financial Results
2019-08-05 12:18:45 | Some Accelerate Diagnostics NASDAQ:AXDX Shareholders Are Down 19%
2019-07-15 14:15:15 | Arizona's most-profitable public companies raked in billions in 2018
2019-07-08 08:30:00 | Accelerate Diagnostics Schedules Call to Review Second Quarter 2019 Results
2019-06-13 08:06:40 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.
2019-06-10 08:07:48 | See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.